• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 54
      #AHA24 Late-Breaking and Featured Science announced - 8 month(s) ago

      See the impressive lineup of science planned for presentation at Scientific Sessions 2024.

      Source: sessions.hub.heart.org
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        #AHA24 Late-Breaking trials announced. A lot of interesting things and nothing that blew me away. But, you know, prevention is the new intervention, right? https://t.co/pbDF2T0Am4 There is more for us interventional cardiologists at #TCT2024 this year, with highly anticipated… https://t.co/S18gIvsci3

    • Mashup Score: 52
      #AHA24 Late-Breaking and Featured Science announced - 8 month(s) ago

      See the impressive lineup of science planned for presentation at Scientific Sessions 2024.

      Source: sessions.hub.heart.org
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        #AHA24 Late-Breaking trials announced. A lot of interesting things and nothing that blew me away. But, you know, prevention is the new intervention, right? https://t.co/pbDF2T0Am4 There is more for us interventional cardiologists at #TCT2024 this year, with highly anticipated… https://t.co/S18gIvsci3

    • Mashup Score: 228
      Three-year outcomes of EuroCTO (A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions) - 9 month(s) ago

      The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

      Source: eurointervention.pcronline.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        In the randomized, multicenter, unblinded EURO-CTO trial, the incidence of cardiovascular death or nonfatal myocardial infarction at 3 years was not significantly different between PCI and optimal medical therapy among 396 with a symptomatic CTO lesion. https://t.co/6sKcU5ZTLP https://t.co/QCwQFvIpsa

    • Mashup Score: 228
      Three-year outcomes of EuroCTO (A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions) - 9 month(s) ago

      The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

      Source: eurointervention.pcronline.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        In the randomized, multicenter, unblinded EURO-CTO trial, the incidence of cardiovascular death or nonfatal myocardial infarction at 3 years was not significantly different between PCI and optimal medical therapy among 396 with a symptomatic CTO lesion. https://t.co/6sKcU5ZTLP https://t.co/QCwQFvIpsa

    • Mashup Score: 242
      Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA - 10 month(s) ago

      This study investigated the relationship between saline-induced hyperemia and exercise-induced coronary flow regulation in patients with angina and non-obstructive coronary artery disease.

      Source: eurointervention.pcronline.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        I wonder if the inventor of coronary angiography anticipated this development. https://t.co/KO9pMuriV1 https://t.co/deezUAAd1O

    • Mashup Score: 240
      Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA - 10 month(s) ago

      This study investigated the relationship between saline-induced hyperemia and exercise-induced coronary flow regulation in patients with angina and non-obstructive coronary artery disease.

      Source: eurointervention.pcronline.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        I wonder if the inventor of coronary angiography anticipated this development. https://t.co/KO9pMuriV1 https://t.co/deezUAAd1O

    • Mashup Score: 235
      Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA - 10 month(s) ago

      This study investigated the relationship between saline-induced hyperemia and exercise-induced coronary flow regulation in patients with angina and non-obstructive coronary artery disease.

      Source: eurointervention.pcronline.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        I wonder if the inventor of coronary angiography anticipated this development. https://t.co/KO9pMuriV1 https://t.co/deezUAAd1O

    • Mashup Score: 220
      Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA - 10 month(s) ago

      This study investigated the relationship between saline-induced hyperemia and exercise-induced coronary flow regulation in patients with angina and non-obstructive coronary artery disease.

      Source: eurointervention.pcronline.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        I wonder if the inventor of coronary angiography anticipated this development. https://t.co/KO9pMuriV1 https://t.co/deezUAAd1O

    • Mashup Score: 75
      RECOVER IV Impella Trial Halted in the Wake of DanGer Shock - 12 month(s) ago

      With the first positive results from a cardiogenic-shock RCT in hand, researchers are brainstorming what should come next.

      Source: www.tctmd.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        I showed this trial design slide less than one week ago at @CCCSymposium_NY and it did not age well. https://t.co/Yfp9YTfNDH https://t.co/5VbRoKTfDH

    • Mashup Score: 75
      RECOVER IV Impella Trial Halted in the Wake of DanGer Shock - 12 month(s) ago

      With the first positive results from a cardiogenic-shock RCT in hand, researchers are brainstorming what should come next.

      Source: www.tctmd.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	DFCapodanno
        DFCapodanno

        I showed this trial design slide less than one week ago at @CCCSymposium_NY and it did not age well. https://t.co/Yfp9YTfNDH https://t.co/5VbRoKTfDH

    Load More

    Davide Capodanno

    @DFCapodanno

    Interventional Cardiologist | University of Catania, Italy | Editor @EuroInterventio

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings